%D9%81%D9%82%D8%B1_%D8%AF%D9%85_%D9%81%D8%A7%D9%86%D9%83%D9%88%D9%86%D9%8AAn%C3%A8mia_de_FanconiCategory:Fanconi_anemiaFanconi-An%C3%A4mieFanconi_anemiaAnemia_de_Fanconi%D8%A2%D9%86%D9%85%DB%8C_%D9%81%D8%A7%D9%86%DA%A9%D9%88%D9%86%DB%8CFanconin_anemiaAn%C3%A9mie_de_FanconiAnemia_de_Fanconi%D7%90%D7%A0%D7%9E%D7%99%D7%94_%D7%A2%D7%9C_%D7%A9%D7%9D_%D7%A4%D7%A0%D7%A7%D7%95%D7%A0%D7%99Fanconijeva_anemijaFanconi-an%C3%A9miaAnemia_di_Fanconi%E3%83%95%E3%82%A1%E3%83%B3%E3%82%B3%E3%83%BC%E3%83%8B%E8%B2%A7%E8%A1%80%ED%8C%90%EC%BD%94%EB%8B%88_%EB%B9%88%ED%98%88Anemie_van_FanconiNiedokrwisto%C5%9B%C4%87_FanconiegoAnemia_de_Fanconi%D0%90%D0%BD%D0%B5%D0%BC%D0%B8%D1%8F_%D0%A4%D0%B0%D0%BD%D0%BA%D0%BE%D0%BD%D0%B8Fanconi_anemiaFanconis_anemiQ845779%E8%8C%83%E5%B9%B2%E5%B0%BC%E6%B0%8F%E8%B2%A7%E8%A1%80
about
Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure SyndromesUnrelated HSCT in Patients With Fanconi AnemiaStudy of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant PatientsStudy of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant PatientsStudy of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi AnemiaLentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype AFludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi AnemiaHematopoietic Stem Cell Transplant for Fanconi AnemiaUse Massive Parallel Sequencing and Exome Capture Technology to Sequence the Exome of Fanconi Anemia Children and Their PatentsUmbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant DiseasesQuercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi AnemiaMicrocephaly Genetic Deficiency in Neural ProgenitorsAlefacept and Allogeneic Hematopoietic Stem Cell TransplantationGene Therapy for Fanconi AnemiaStudy of Fludarabine Drug Exposure in Pediatric Bone Marrow TransplantationCure Cystinosis International RegistryA Clinical Trial to Evaluate the Safety of RP-L102 in Pediatric Subjects With Fanconi Anemia Subtype ALong Term Follow-up Study for Patients Enrolled on the BP-004 Clinical StudyCancer in Inherited Bone Marrow Failure SyndromesWidefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral CancerFamilial Investigations of Childhood Cancer PredispositionBiomarker for Cystinosis Disease: BioCystinosisIdentification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid LeukemiaSafety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell TransplantBMT Abatacept for Non-Malignant DiseasesQuercetin in Children With Fanconi Anemia; a Pilot StudySafety and Efficacy Trial of Danazol in Patients With Fanconi Anemia or Dyskeratosis CongenitaHematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and FludarabineRisk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant DiseasesResearch Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or MyelomaTissue Sample Collection From Patients With Fanconi AnemiaGene Function in Bone Marrow Cells From Patients With Fanconi Anemia and From Healthy ParticipantsFludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure DisordersHematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and FludarabineAntibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fanconi AnemiaUse of Rft5-Dga to Deplete Alloreactive Cells for Pts With Fanconi Anemia After Haploidentical SCTT Cell Receptor α/β TCD HCT in Patients With Fanconi AnemiaPilot Study of Metformin for Patients With Fanconi AnemiaFANCA Gene Transfer for Fanconi Anemia Using a High-safety, High-efficiency, Self-inactivating Lentiviral Vector
P1050
P1889
P1916
Fanconi anemia complementation group VFanconi anemia complementation group TFanconi anemia complementation group LFanconi anemia complementation group D2Fanconi anemia complementation group EFanconi anemia complementation group UFanconi anemia complementation group GFanconi anemia complementation group CFanconi anemia complementation group FFanconi anemia complementation group D1Fanconi anemia complementation group RFanconi anemia complementation group IFanconi anemia complementation group PFanconi anemia complementation group QFanconi anemia complementation group NFanconi anemia complementation group AFanconi anemia complementation group OFanconi anemia complementation group JFanconi anemia complementation group B
P279
Update of the human and mouse Fanconi anemia genesExploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer TherapyLearning from a paradox: recent insights into Fanconi anaemia through studying mouse modelsThe Fanconi anemia pathway and ubiquitinA case report and literature review of Fanconi Anemia (FA) diagnosed by genetic testing.Pregnancy in fanconi anaemia with bone marrow failure: a case report and review of the literatureEnhancing the efficacy of engraftment of cord blood for hematopoietic cell transplantationFanconi anemia: a signal transduction and DNA repair pathway.RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer.Nuclease delivery: versatile functions of SLX4/FANCP in genome maintenance.FANCD2 and DNA Damage.A plea to provide best evidence in trials under sample-size restrictions: the example of pioglitazone to resolve leukoplakia and erythroplakia in Fanconi anemia patients.Risk of Human Papillomavirus Infection in Cancer-Prone Individuals: What We Know.The Fanconi anemia pathway of genomic maintenance.Ubiquitylation at the Fork: Making and Breaking Chains to Complete DNA ReplicationAcute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant TransplantSafety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant DiseasesQuercetin in Children With Fanconi Anemia; a Pilot StudyResearch Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or MyelomaTissue Sample Collection From Patients With Fanconi AnemiaGene Function in Bone Marrow Cells From Patients With Fanconi Anemia and From Healthy ParticipantsAntibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fanconi AnemiaPilot Study of Metformin for Patients With Fanconi AnemiaFANCA Gene Transfer for Fanconi Anemia Using a High-safety, High-efficiency, Self-inactivating Lentiviral VectorMulticenter Transplant Study for Fanconi AnemiaPilot Study of Etanercept (Enbrel) in Children With Fanconi AnemiaCytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi AnemiaAssessing Immune Function in Young Patients With Cytopenia That Did Not Respond to TreatmentCyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Fanconi's AnemiaMobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and PlerixaforBusulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia inHematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi AnemiaOxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi AnemiaGene Therapy for the Treatment of Fanconi's Anemia Type CA Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair DeficiencyA Phase 1/2 Trial of SRA737 in Combination With Gemcitabine Plus Cisplatin or Gemcitabine Alone in Subjects With Advanced CancerA Phase 1/2 Trial of SRA737 in Subjects With Advanced CancerDonor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer (1999-10-31)
P921
Q61729665-8F91B006-3167-4DD0-BA5E-74B1025E4EB8Q61894596-1C12B5F1-590E-4C47-8C63-8E31096AA683Q61906925-0E0B3FEC-12A2-48F8-B2CE-2F0A689E3844Q61906926-35DF7A4C-1AD9-46CC-85E3-88AEB0BFC629Q61906927-E6C6145B-7687-4713-8996-D586D0CDD46AQ61907674-3D5D5E22-CDC1-4EC3-B84C-EC869C0FFA09Q61909476-59C3D789-B838-4DE4-A93B-060A35E2E804Q61920801-3C7ABAE8-1BF6-4112-977A-07D48D1C20D3Q61938712-B7D403CC-C942-4A07-BD05-DE9EED359BB6Q61969698-F30753F5-123C-4286-809E-2FA2636A621DQ62110734-45944CB8-5AC6-4A0C-B079-12F9AE6CED8FQ62813559-77D2D5EF-F7E8-407C-8799-0F98999ADB21Q63315763-A8002ECC-0D7F-4E2F-850F-43C055BDE70DQ63336803-FD392355-BF35-46D0-A7B1-615D077F1013Q63337791-FC8A8FC5-CE42-475F-B3C2-7EACF3D12AC0Q63338024-0C4934DF-3478-4D5C-AE84-996044F2EDB5Q63338656-B90FB9B2-CF16-46BF-8F23-A845D4A65731Q63582523-D54E6CA1-B777-407B-B8D6-4A13DC1FA70BQ63596623-A2BFE83B-CAFF-40C0-B07C-1EAF0D01CADCQ63804986-17195D50-1F95-4F82-AD82-6846906F8F66Q63808090-294D40F3-92BC-4687-B3C2-F24048966818Q63813116-B64833E6-230B-47E3-83C0-EE903E309AE0Q63813263-19AF2972-1E71-4C6B-B149-E846200E068FQ63830963-C4BFBDEB-0CF7-4CE4-9E39-5D16455A1935Q64223062-0A8C3CEE-1E39-4374-84A8-7E8785A767F2Q64622785-CDC82B61-DFFF-4C1F-83AE-8C3732183ABEQ64638585-AA87DB01-80BF-4C62-B19D-8540FCCDA024Q64661076-2C115948-0BD4-49F3-ABB1-1D8A85E8064AQ64662031-9E64F462-54D1-4D01-A7C8-06B42935F66EQ64666231-FFDF1C1E-E6DD-44AD-AA65-DE49C1A18B9DQ64676217-1D6D813F-4B47-44CA-8902-6ED1DE333F7BQ64676252-9C415CD7-AC49-4B49-9E66-94DC37A6EE7BQ64677174-CFE8FDAB-01FE-45B8-B5DB-2C0180464478Q64679286-F7C95914-D80C-4580-A43E-C475D6A7ABB9Q64724634-00CF0839-9884-4498-B06B-7A1FC0542891Q64725377-0D09EE6A-B06F-4A46-83D6-E69ACD2DBB27Q64726153-0EFD1F3D-0AFE-4505-AA34-A9197293DC03Q64795177-A7D8BDBC-C8C1-45F6-AA9D-EF5791A4081FQ64804171-7A3507E6-6397-4BEC-A68E-70E50DC68E1DQ64808484-174824BA-EC09-4544-9D2D-F917E04A6EE8
P1050
description
Angeborene aplastische Anämie
@de
Human disease
@en
مرض يصيب الإنسان
@ar
name
Anemia de Fanconi
@gl
Fanconi anemia
@en
Fanconi-Anämie
@de
Fanconi-anemie
@nl
Fanconi-anémia
@hu
Fanconijeva anemija
@hr
Fanconin anemia
@fi
Fanconis anemi
@sv
Niedokrwistość Fanconiego
@pl
anemia de Fanconi
@es
type
label
Anemia de Fanconi
@gl
Fanconi anemia
@en
Fanconi-Anämie
@de
Fanconi-anemie
@nl
Fanconi-anémia
@hu
Fanconijeva anemija
@hr
Fanconin anemia
@fi
Fanconis anemi
@sv
Niedokrwistość Fanconiego
@pl
anemia de Fanconi
@es
altLabel
Anemia Fanconiego
@pl
Constitutionele aplastische anemie
@nl
Fanconi anemie
@nl
Fanconi pancytopenia
@en
Fanconi panmyelopathy
@en
Fanconi's anemia
@en
Fanconianemi
@sv
Malattia di Fanconi
@it
anemie de Fanconi
@fr
anèmia aplàstica familiar
@ca
prefLabel
Anemia de Fanconi
@gl
Fanconi anemia
@en
Fanconi-Anämie
@de
Fanconi-anemie
@nl
Fanconi-anémia
@hu
Fanconijeva anemija
@hr
Fanconin anemia
@fi
Fanconis anemi
@sv
Niedokrwistość Fanconiego
@pl
anemia de Fanconi
@es
P2888
P672
P486
P5806
P6366
P646
P1296
P1325
P138
P1417
science/Fanconi-anemia